Frontiers in Oncology | Cancer Immunity and Immunotherapy

Systematic Review

Published on 29 Sep 2023

PD-1/PD-L1 inhibitor treatment and its impact on clinical imaging in non-small cell lung cancer: a systematic review and meta-analysis of immune-related adverse events

in Cancer Immunity and Immunotherapy

Nader Mohammed
En-Hua Xiao
Shallal Mohsen
Zeng Xiong
RongRong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1191681

3,197 views
3 citations

Original Research

Published on 28 Sep 2023

Study of prevalence and risk factors of chemotherapy-induced mucositis in gastrointestinal cancer using machine learning models

in Cancer Immunity and Immunotherapy

Lin Huang
Xianhui Ye
Fengqing Wu
Xiuyun Wang
Meng Qiu

Frontiers in Oncology

doi 10.3389/fonc.2023.1138992

2,797 views
2 citations

Review

Published on 26 Sep 2023

Circadian rhythm disorders in patients with advanced cancer: a scoping review

in Cancer Immunity and Immunotherapy

Craig Gouldthorpe
Jenny Power
Andrew Davies

Frontiers in Oncology

doi 10.3389/fonc.2023.1240284

2,987 views
3 citations

Review

Published on 22 Sep 2023

The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer

in Cancer Immunity and Immunotherapy

Yihan Sun
Genyi Jiang
Qianhua Wu
Lei Ye
Bilan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1213347

4,737 views
8 citations

Original Research

Published on 22 Sep 2023

A nomogram based on the preoperative neutrophil-to-lymphocyte ratio to distinguish sarcomatoid renal cell carcinoma from clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Yijian Wu
Tienan Qi
Xin Qin
Zhongwei Zhao
Jianguo Zheng
Qinglong Du
Nengwang Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1218280

1,805 views

Original Research

Published on 19 Sep 2023

Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer

in Cancer Immunity and Immunotherapy

Dandan Zhan
Xuan Wang
Yifeng Zheng
Shengqi Wang
Bowen Yang
Bo Pan
Neng Wang
Zhiyu Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1147189

3,901 views
9 citations

Original Research

Published on 19 Sep 2023

The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China

in Cancer Immunity and Immunotherapy

Yu Xiong
Pingzheng Mo
Yajun Yan
Shan Wang
Ke Zhuang
Zhiyong Ma
Xiaoping Chen
Liping Deng
Yong Xiong
Di Deng

Frontiers in Oncology

doi 10.3389/fonc.2023.1248790

2,499 views
3 citations

Review

Published on 15 Sep 2023

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights

in Cancer Immunity and Immunotherapy

Randolph J. Noelle
J. Louise Lines
Lionel D. Lewis
Robert E. Martell
Thierry Guillaudeux
Sam W. Lee
Kathleen M. Mahoney
Matthew D. Vesely
Jerome Boyd-Kirkup
Dhanya K. Nambiar

Frontiers in Oncology

doi 10.3389/fonc.2023.1225081

6,551 views
12 citations

Original Research

Published on 15 Sep 2023

Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancer

in Cancer Immunity and Immunotherapy

Iori Motoo
Takayuki Ando
Takeru Hamashima
Shinya Kajiura
Miho Sakumura
Yuko Ueda
Aiko Murayama
Kohei Ogawa
Kenichiro Tsukada
Akira Ueda

Frontiers in Oncology

doi 10.3389/fonc.2023.1193533

2,747 views
4 citations

Review

Published on 15 Sep 2023

Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment

in Cancer Immunity and Immunotherapy

Pei Wang
Xiao-Yan Wang
Chang-Feng Man
Dan-Dan Gong
Yu Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1200619

11,294 views
5 citations

Original Research

Published on 14 Sep 2023

Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features

in Cancer Immunity and Immunotherapy

Yijun Song
Jiebai Zhou
Xiaotian Zhao
Yong Zhang
Xiaobo Xu
Donghui Zhang
Jiaohui Pang
Hairong Bao
Yuan Ji
Mengna Zhan

Frontiers in Oncology

doi 10.3389/fonc.2023.1237308

2,672 views
2 citations

Original Research

Published on 14 Sep 2023

The role of tumor-associated macrophages in glioma cohort: through both traditional RNA sequencing and single cell RNA sequencing

in Cancer Immunity and Immunotherapy

Yunan Hou
Wenjin Qiu
Yuanguo Ling
Xiaolan Qi
Jian Liu
Hua Yang
Liangzhao Chu

Frontiers in Oncology

doi 10.3389/fonc.2023.1249448

2,318 views
4 citations

Case Report

Published on 14 Sep 2023

Case Report: sintilimab-induced Stevens-Johnson Syndrome in a patient with advanced lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Xueqin Li
Guanghui Li
Diangang Chen
Linxi Su
Ru-peng Wang
Yi Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.912168

2,174 views
6 citations

Case Report

Published on 08 Sep 2023

Case Report: Response to ipilimumab and nivolumab in a patient with adrenocortical carcinoma

in Cancer Immunity and Immunotherapy

Rebecca Charles
Divine Madhu
Alexander Powles
Adam Boyde
Owen Hughes
Nagappan Kumar
Sing Yu Moorcraft

Frontiers in Oncology

doi 10.3389/fonc.2023.1242560

2,170 views
1 citation

Mini Review

Published on 07 Sep 2023

Circadian, hormonal, and sleep rhythms: effects on cancer progression implications for treatment

in Cancer Immunity and Immunotherapy

Annemarie D. Jagielo
Catherine Benedict
David Spiegel

Frontiers in Oncology

doi 10.3389/fonc.2023.1269378

3,737 views
4 citations

Review

Published on 05 Sep 2023

ExoPD-L1: an assistant for tumor progression and potential diagnostic marker

in Cancer Immunity and Immunotherapy

Rong Hu
Md Shoykot Jahan
Lijun Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1194180

3,022 views
10 citations